Listed by the USPTO as ROZANSKI, GRACE NMN
Tech Center 3700 • Art Units: 3791 3798
This examiner grants 60% of resolved cases
ROZANSKI, GRACE NMN has resolved 86 cases in Tech Center 3700 and Art Unit 3791. The allowance rate is 60.5%, and the interview lift is 20.7%. The median time to allowance is 1511 days. The profile indicates a moderate allowance rate, a positive interview association, and a long median time to allowance.
Medtronic Minimed Inc., Abbott Laboratories, and Heartflow Inc. are the listed leading companies. Gates & Cooper LLP - Minimed, Bookoff McAndrews, PLLC, and SUGHRUE MION, PLLC are the listed leading firms. The smaller resolved-case record counsels against treating the metrics as conclusive, but the duration supports early attention to prosecution planning. Interviews may be useful when they can reduce uncertainty around the outstanding issues.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18284324 | BIOMETRIC INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING SYSTEM, BIOMETRIC INFORMATION PROCESSING METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 18792250 | METHOD, MEDICAL SYSTEM, AND MEDIUM | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18960722 | WEARABLE DETECTION METHOD FOR WEARING DEVICE AND WEARABLE DEVICE | Non-Final OA | Huawei Technologies Co., Ltd. |
| 17510802 | FIBROUS COVER LAYER FOR MEDICAL DEVICES | Final Rejection | Cardiac Pacemakers, Inc. |
| 17399857 | SYSTEMS, DEVICES, AND METHODS FOR ANALYTE SENSOR APPLICATORS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17347869 | ANALYTE SENSORS FEATURING A REDUCED-AREA WORKING ELECTRODE FOR DECREASING INTERFERENT SIGNAL | Final Rejection | ABBOTT DIABETES CARE INC. |
| 19120394 | SYSTEMS AND METHODS FOR ACOUSTIC-BASED DIAGNOSIS | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17778886 | Multilayer Adhesive Fluid Collection Articles Including Capillary Channels | Non-Final OA | Solventum Intellectual Properties Company |
| 18666596 | INTERFERENCE REJECTION MEMBRANES USEFUL WITH ANALYTE SENSORS | Final Rejection | Medtronic MiniMed, Inc. |
| 18366299 | SENSORS FOR 3-HYDROXYBUTYRATE DETECTION | Final Rejection | Medtronic MiniMed, Inc. |
| 18344273 | ACRYLATE HYDROGEL MEMBRANE FOR DUAL FUNCTION OF DIFFUSION LIMITING MEMBRANE AS WELL AS ATTENUATION TO THE FOREIGN BODY RESPONSE | Final Rejection | Medtronic MiniMed, Inc. |
| 18225403 | WEARABLE MICROFLUIDIC BIOAFFINITY SENSOR FOR AUTOMATIC MOLECULAR ANALYSIS | Non-Final OA | California Institute of Technology |
| 18735242 | GUIDE WIRE | Non-Final OA | ASAHI INTECC CO., LTD. |
| 18067427 | ANALYTE SENSOR DEPLOYMENT TESTING | Non-Final OA | Dexcom, Inc. |
| 18430270 | PRO-ICTAL STATE CLASSIFIER | Final Rejection | The Board of Regents of the University of Texas System |
| 17849840 | ELECTROCHEMICAL SENSOR SYSTEM AND METHOD FOR ASCORBIC ACID MEASUREMENT | Final Rejection | Purdue Research Foundation |
| 18871274 | METHOD OF ADJUSTING PULSE WAVE MEASUREMENT DEVICE, PULSE WAVE MEASUREMENT SYSTEM, AND PULSE WAVE MEASUREMENT DEVICE | Non-Final OA | MINEBEA MITSUMI Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy60.5% of resolved applications examined by Grace Nmn Rozanski were allowed (86 resolved cases), compared with 53.3% across Art Unit 3791 over the last five years.
This examiner's interview lift is +20.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Grace Nmn Rozanski took 1,511 days on average from filing to allowance.
Grace Nmn Rozanski examines applications in Art Unit 3791 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
